Reduced injection risk behavior with co-located hepatitis C treatment at a syringe service program: The accessible care model.  Lee CSJ, Mateu-Gelabert P, Melendez YA, Fong C, Kapadia SN, Smith M, Marks KM, Eckhardt B.  PLoS One. 2024 ...

Gender affirming harm reduction: A toolkit for syringe service programs The purpose of this living document is to assist service providers in better understanding the needs of the trans, gender nonconforming, and nonbinary (TGNCNB) community when...

Unmet needs and harm reduction preferences of syringe services program participants: differences by co-use of illicit opioids and methamphetamine.  Sun R, Sauda TH, Hoopsick RA.  Harm Reduct J. 2024 Jun 19;21(1):119. doi: 10.1186/s1295...

Providing medication for opioid use disorder and HIV pre-exposure prophylaxis at syringe services programs via telemedicine: a pilot study.  McKellar MS, Des Marais AC, Chen H, Choi Y, Lilly R, Ayers D, Bennett J, Kestner L, Perry B, Poley S...

Updates on syringe coverage and service uptake among needle and syringe programs in the United States, 2019-2020.  Tookes HE, Bartholomew TS, Sugar SES, Plesons MD, Bluthenthal RN, Wenger LD, Patel SV, Kral AH, Lambdin BH.  Int J Drug ...

EMCDDA. Most recent data from the European Syringe Collection and Analysis Project Enterprise (ESCAPE): data explorer, analysis and key findings  Background and introduction While evidence from drug treatment centres suggests that injecting...